This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 2583
Title
Increased, estrogens leads to Increased, circulating estrogen levels
Upstream event
Downstream event
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia | adjacent | High | Moderate | Cataia Ives (send email) | Under development: Not open for comment. Do not cite | Under Development |
Taxonomic Applicability
Sex Applicability
| Sex | Evidence |
|---|---|
| Female | High |
| Male | High |
Life Stage Applicability
| Term | Evidence |
|---|---|
| Adult, reproductively mature | High |
Ovaries are the principle source of estrogen hormone in premenopausal women. This estrogen functions as a circulating hormone to act on different tissues. In postmenopausal women, estrogen is produced in a number of extragonadal sites and acts locally at these sites as a paracrine or even intracrine factor. The monthly menstrual cycle in female is controlled through unique co-ordination between secreted hormones by the hypothalamus, the pituitary gland, and the ovary. Estrogen is synthesized from androgen, upon calalysis of aromatse enzyme present in the endoplasmic reticulam of the cells. Presence of aromatase enzyme is found majorly in the ovarian granulosa cells (premenopausal female), in the skin and adipose tissue (postmenopausal woman). Estrogen was synthesized in postmenopausal women due to the aromatization of steroids, found in the adipose and skin tissue.
Aromatase is a key enzyme for estrogen formation in human tissues. In men and postmenopausal women C19 steroids undergoes aromatization in different tissues (e.g. skin, adipose) to generate estrogen. In men, testicular steroidogenesis accounts for 15% of the circulating level of estrogen.
In women, the ovarian granulosa cells are important sites of estrogen formation for local use within the ovary as well as for endocrine signalling to the target tissues (e.g. uterus, skin, breast, brain, bone). In case of postmenopausal female, ovarian aromatase expression is stopped, but estrogen level is maintained in the plasma by the increased aromatase expression in other tissues (adipose and skin). Research had shown elevated circulating estradiol may persist at sufficient levels to cause postmenopausal uterine bleeding, endometrial hyperplasia, and even cancer.
| ID | Experimental Design | Species | Upstream Observation | Downstream Observation | Citation (first author, year) | Notes |
|---|
| Title | First Author | Biological Plausibility |
Dose Concordance |
Temporal Concordance |
Incidence Concordance |
|---|
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
Leung et al., had shown estradiol-17β (I mg) administration in the female rat for 3 days decrease the ovarian androgen levels (13 ± 2 pg/mg) compared to the control (34 ± 7 pg/mg). Results of the study suggest estrogen levels controlled by the negative feedback loop of testosterone production (Leung et al., 1978).
Estrogen levels changes due to the following reasons.
- High androgen levels caused by tumors
- Androgen therapy
- Elevations in estrogen due to aromatization
- Obesity with increased tissue production of E1
- Decreased estrogen clearance in liver disease
- Estrogen producing tumors
- Estrogen ingestion
Estrone concentrations in human
Males: 10-60 pg/mL, Females: Premenopausal: 17-200 pg/mL, Postmenopausal: 7-40 pg/mL
Estradiol concentrations in human
Males: 10-40 pg/mL, Females: Premenopausal: 15-350 pg/mL, Postmenopausal: <10 pg/mL (Cummings et al., 1998; Elmlinger et al., 2002)
Response-response Relationship
Leung et al., had shown estradiol-17β (I mg) administration in the female rat for 3 days decrease the ovarian androgen levels (13 ± 2 pg/mg) compared to the control (34 ± 7 pg/mg) (Leung et al., 1978).
Time-scale
Elevation of the circulating estrogen can be observed in days
Known Feedforward/Feedback loops influencing this KER
Not specified
Judd et al, had measured the circulating estrogen level in the male and female lizards (Iguana iguana) (Judd et al., 1976).
Roberts et al., had estimated the circulating estrogen in the plasma collected from human volunteer (Roberts and Szego, 1946).
Truan et al., had shown the high circulating estrogen levels in the mice model (Truan et al., 2010).